Treatment of Annular Elastolytic Giant Cell Granuloma With …
2024年12月17日 · Annular elastolytic giant cell granuloma (AEGCG), also known as actinic granuloma, is a rare granulomatous skin disorder that usually develops in areas of actinic elastosis. 1 First described in 1975 by O’Brien et al, lesions are characterized by asymptomatic annular plaques with elevated and erythematous borders and slightly atrophic and …
Annular Elastolytic Giant Cell Granuloma Successfully Treated With ...
AEGCG is an uncommon granulomatous skin disease first described by O’Brien in 1975 as actinic granuloma. 1 It is characterized by erythematous papules and plaques that progress to annular lesions with raised borders and central atrophy, 2 in sun-exposed skin. Histological analysis of an AEGCG lesion reveals elastophagocytosis, a granulomatous ...
Treatment of Annular Elastolytic Giant Cell Granuloma With …
2023年8月8日 · AbstractAnnular elastolytic giant cell granuloma, also known as actinic granuloma, is a rare skin condition with a chronic course that is often resistant to treatment. Literature is sparse, and only a handful of case reports are available to guide treatment decisions.
Annular Elastolytic Giant Cell Granuloma Successfully Treated With ...
AbstractWe report a 51-year-old female with a 3-year history of recalcitrant annular elastolytic giant cell granuloma (AEGCG) who was effectively treated with the anti-tumor necrosis factor (TNF)-alpha antibody, adalimumab.
Review of Actinic Keratosis. Part I:Etiology, Epidemiology and …
2024年12月11日 · Presenting with a spectrum of clinical features, actinic keratoses are believed to be predictors and precursors of invasive squamous cell carcinoma. This, the first of a two-part overview, examines the etiology and epidemiology of actinic keratoses, their clinical and histological features and their role in the development of nonmelanoma skin ...
Imiquimod as an Antiangiogenic Agent - JDDonline
Key principles of antiangiogenic therapy are presented to describe how imiquimod may be applied in a well-tolerated fashion to treat a broad range of angiogenesis-dependent dermatological conditions, including actinic keratosis (AK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), lentigo maligna, hemangiomas, Kaposi’s sarcoma ...
Conditions A-Z - JDDonline - Journal of Drugs in Dermatology
We’re here to help and answer any questions you may have. We look forward to hearing from you!
DNA Repair Enzyme Containing Lip Balm for the Treatment of …
Actinic cheilitis (AC), also known as actinic keratosis (AK) of the lips, is a common lesion of the lower lip caused by chronic exposure to ultraviolet light. 1 Among sun-exposed populations, the prevalence of AC is nearly 10%, and most commonly affects white, older males. 2 AC is characterized by scaling, dryness, edema, erythema, tenderness, fissuring, crusting, and …
Periungual Pyogenic Granuloma Following Imatinib Therapy in a …
Pyogenic granuloma is a benign, rapidly growing, acquired vascular tumor, usually presenting as a sessile or polypoid nodule that can often bleed or ulcerate. It is commonly located on the skin of the trunk and the extremities, but it can also originate from the mucous membranes. It may rarely be subcutaneous or intravascular.
Diclofenac Sodium 3% Gel for the Management of Actinic …
Actinic keratosis (AK) is a chronic disease and part of a biologic continuum between photodamaged skin and invasive squamous cell carcinoma (SCC). 1 Long-term management is required for AK because photodamage occurs over wide areas of sun-exposed skin, and new or recurrent lesions continue to develop on a background of field cancerization. 1-3 Although …